🇺🇸 FDA
Patent

US 8124802

MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity

granted A61PA61P25/00A61P3/04

Quick answer

US patent 8124802 (MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity) held by Jenrin Discovery, LLC expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jenrin Discovery, LLC
Grant date
Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P25/00, A61P3/04, A61P3/10